Alcoholic liver disease (ALD) is a major cause of
liver disease worldwide. In patients with ALD, an increased level of hepatic
inflammasome components was observed, together with an increased circulating pro-inflammatory
cytokines. Cyanidin-3-O-β-glucoside (Cy-3-G) is a bioactive compound belonging to the
anthocyanin group, which widely exists in deep-colored fruits and vegetables. Consumption of Cy-3-G is associated with lower risks of
non-alcoholic fatty liver disease (
NAFLD),
liver fibrosis,
obesity,
atherosclerosis, and
inflammation. However, whether Cy-3-G has effects on
inflammasome formation and activation thereby protects against alcohol-induced liver damage remain elusive. In this study, we identified that dietary provision of Cy-3-G remarkably attenuated liver damage caused by excess energy intake and alcohol consumption. Supplement with Cy-3-G mediated NAD+ homeostasis, which stimulated
SirT1 activity, resulting in suppressed NF-κB acetylation. Interestingly, Cy-3-G treatment suppressed NF-κB acetylation when
SirT1 action was blunted by selective antagonist, and subsequently suppressed NLRP3
inflammasome activation and proinflammatory
cytokines release in hepatic cell lines. Our findings first demonstrate that Cy-3-G at a physiologically achievable dosage alleviates alcohol-induced hepatic
inflammation via inactivation of NLRP3
inflammasome and deacetylation of NF-κB, suggesting a promising therapeutic approach to alleviate alcohol-induced liver damage.